DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹440 Cr | ₹264 Cr | ₹332 Cr | ₹326 Cr | ₹274 Cr |
What is the latest Operating Profit of DISHMAN CARBOGEN AMCIS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹440 Cr |
| Mar2025 | ₹264 Cr |
| Mar2024 | ₹332 Cr |
| Mar2023 | ₹326 Cr |
| Mar2022 | ₹274 Cr |
How is Operating Profit of DISHMAN CARBOGEN AMCIS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹440 Cr | 66.61 | |
| Mar2025 | ₹264 Cr | -20.55 | |
| Mar2024 | ₹332 Cr | 2.01 | |
| Mar2023 | ₹326 Cr | 18.76 | |
| Mar2022 | ₹274 Cr | - | |
Compare Operating Profit of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,341.0 Cr | -1.2% | -14.1% | -48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -1.2% |
-14.1% |
-48.3% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses